Among the five signature genes, the high expression of PDXK in HCC tumor samples were confirmed by the Western Blot and IHC, and the high expression of PDXK indicated a worse survival in our clinical cohorts. The gene discussed is PDXK; the disease is hepatocellular carcinoma.